Twist Bioscience Corp (TWST) Costs and Expenses USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Twist Bioscience Corp quarterly/annual Costs and Expenses history and growth rate from 2018 to 2024.
  • Twist Bioscience Corp Costs and Expenses for the quarter ending March 31, 2024 was $124 M, a 1.95% increase year-over-year.
  • Twist Bioscience Corp Costs and Expenses for the twelve months ending March 31, 2024 was $484 M, a 7.1% increase year-over-year.
  • Twist Bioscience Corp annual Costs and Expenses for 2023 was $462 M, a 5.46% increase from 2022.
  • Twist Bioscience Corp annual Costs and Expenses for 2022 was $438 M, a 53.8% increase from 2021.
  • Twist Bioscience Corp annual Costs and Expenses for 2021 was $285 M, a 23.8% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $484 M $124 M +$2.37 M +1.95% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $482 M $118 M +$19.6 M +19.8% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-02
Q3 2023 $462 M $117 M +$2.88 M +2.52% Jul 1, 2023 Sep 30, 2023 10-K 2023-11-21
Q2 2023 $459 M $125 M +$7.25 M +6.18% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $452 M $122 M +$12.9 M +11.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $439 M $98.9 M +$915 K +0.93% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-02
Q3 2022 $438 M $114 M +$36.4 M +46.8% Jul 1, 2022 Sep 30, 2022 10-K 2023-11-21
Q2 2022 $402 M $117 M +$40.1 M +52% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $362 M $109 M +$39.7 M +57.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $322 M $98 M +$37 M +60.7% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-07
Q3 2021 $285 M $77.8 M +$21.4 M +37.9% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-21
Q2 2021 $264 M $77.1 M +$27.7 M +56.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $236 M $69.2 M +$17.8 M +34.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $218 M $61 M -$12 M -16.5% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 $230 M $56.4 M +$9.09 M +19.2% Jul 1, 2020 Sep 30, 2020 10-K/A 2023-06-05
Q2 2020 $221 M $49.4 M +$7.68 M +18.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $213 M $51.4 M +$11.6 M +29% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $202 M $73 M +$38.6 M +112% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 $163 M $47.3 M Jul 1, 2019 Sep 30, 2019 10-K 2021-11-23
Q2 2019 $41.7 M +$17.7 M +73.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $39.8 M +$17 M +74.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $34.4 M Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q2 2018 $24 M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $22.8 M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.